Maven Bio logo

Maven Bio

Emerging

Boston biopharma AI platform automating competitive landscape, regulatory intelligence, and clinical research for DayOne and ZS Associates; YC $3.1M Pags/Splash seed competing with Citeline and Evaluate for AI-powered pharma knowledge work.

37
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About Maven Bio

Maven Bio is a Boston, Massachusetts-based AI platform for biopharma knowledge work — backed by Y Combinator with $3.1 million in seed funding led by Pags Group, Splash Capital, and NVO Group with YC participation, following a $500,000 pre-seed from YC in September 2023 — providing biopharma companies, consultancies, and investors with domain-specific AI modules built on curated biopharma industry data that automate the research, analysis, and synthesis tasks that pharmaceutical knowledge workers perform manually. Founded in 2023 by Michael Brady and Arjun Murthy and operating with an 8-person team in Boston, Maven Bio serves customers including DayOne and ZS Associates (the global biopharma consulting firm) with a platform that converts biopharma questions into decisions faster through AI-powered access to curated drug development, clinical, and regulatory knowledge.

Business Model & Competitive Advantage

Maven Bio's product suite addresses the knowledge bottleneck in pharmaceutical decision-making: biopharma professionals (drug developers, market access teams, medical affairs, investors evaluating deals) spend significant time researching the competitive landscape (finding all drugs in development for a target indication), regulatory history (understanding FDA precedents for a drug class), payer coverage patterns (identifying how commercial payers currently reimburse similar products), and clinical evidence (synthesizing trial design and outcomes across therapeutic area literature). Each of these research tasks currently requires hours of database querying, literature review, and manual synthesis that Maven's domain-specific AI modules — Maven Atlas (competitive landscape mapping), Maven Compass (regulatory intelligence), Maven Workflows (automated research workflows), and Maven Assistant (conversational research interface) — execute in minutes using curated, validated biopharma data sources rather than the hallucination-prone general web searches that generic LLMs use for specialized pharmaceutical questions.

Competitive Landscape 2025–2026

In 2025, Maven Bio competes in the biopharma AI, pharmaceutical intelligence, and life sciences knowledge management market with Citeline (formerly Informa Pharma Intelligence, clinical trial databases), Evaluate (pharma market intelligence, acquired by Norstella), and Cradle (AI for drug design, $24M raised) for biopharma team and investor AI-powered pharmaceutical intelligence adoption. The biopharma domain-specific AI market has differentiated from general LLM access by offering curated, validated pharmaceutical data sets that reduce the hallucination risk inherent in asking general AI assistants about drug mechanisms, clinical trial designs, or regulatory precedents — domains where inaccuracy creates liability and decision risk. ZS Associates' customer status (ZS is one of the world's leading pharmaceutical consulting firms) validates Maven Bio's accuracy and relevance for professional biopharma decision support. Y Combinator backing connects Maven with the biotech and healthcare AI investor community. The 2025 strategy focuses on growing the enterprise biopharma consulting and pharma company subscriptions, building the deal analysis module for pharmaceutical BD and licensing evaluation, and expanding the real-world evidence integration for payer evidence and outcomes data.

Founded
2023
Headquarters
Maven Bio is a Boston, Massachusetts
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Maven Bio is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

37
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

Compare Maven Bio with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Maven Bio

Claim This Profile

Are you from Maven Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Maven Bio Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Maven Bio vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →